Has Scott Olson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $104,676 in general payments to Scott Olson, MD across 259 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Scott Olson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Scott Olson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Scott Olson, MD

Neurological Surgery · la Jolla, CANPI 1376568659

Payments from drug & device makers

$104,676in general payments, 2019–2025

Across 259 payments — averaging $404.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Microvention, Inc.$77K
Medtronic$27K
Johnson & Johnson$483
Stryker$406
Boston Scientific$140
Shionogi Inc$34
plus $68 from 3 others

What the payments were for

Consulting fees$12,60012%
Speaking & faculty fees$75,35072%
Travel & lodging$11,01811%
Food & beverage$5,7085%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Microvention, Inc.	148	$76,693
Medtronic(2 entities)	70	$26,852
Johnson & Johnson	22	$483
Stryker	11	$406
Boston Scientific	3	$140
Shionogi Inc	2	$34
Neurelis, Inc.	1	$27
SK Life Science, Inc.	1	$22
Imperative Care, Inc	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$104,676 in reported general payments places this provider in the 80th percentile of 773 neurological surgery providers in California.

See all neurological surgery providers in California →

Medicare billing

Part B allowed, 2024

$95,559

Medicare patients

182

Services billed

513

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	12	$116

Paid to pharmacies, not to this prescriber.

Other neurological surgery in la Jolla

Geoffrey ManleySan Francisco$24.9M
Christopher AmesSan Francisco$7.1M
Jamshid SalehRedding$4.1M
Bruce McCormackSan Francisco$3.9M
Andrew SchreiberSanta Ana$3.9M
Larry KhooLos Angeles$3M
Jennie TaylorSan Francisco$2.7M
Joseph CiacciSan Diego$2.6M
Nicholas ButowskiSan Francisco$2.4M
Samy AbdouSan Diego$2.4M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →